HpaII and MspI, accounts for 8% of CpG sites in the human genome (12) ; among these, 21% are in CpG islands that are predominantly unmethylated and can be cut by HpaII, while 79% are in non-CpG island DNA (13) , in which CpG residues are predominantly methylated and not digested by HpaII (14, 15) . The wide distribution of the CCGG sequence in euchromatin and heterochromatin can therefore provide an indicator of the global cytosine-methylation level in a cell or tissue sample.
The extent of methylation of CpG sites in restriction enzyme cleavage sites can be measured using the cytosine extension assay (CEA), first described in 1999 by Pogribny et al. (16) . This assay is based on the use of methylation-sensitive restriction endonucleases (HpaII, AciI, BssHII) that leave a 5´-guanine overhang after DNA cleavage, which can then be extended using DNA polymerase and [H 3 ]dCTP and detected by scintillation counting, with normalization of samples based on DNA content. A modification using biotin-dCTP to extend the cut sites was described later (17) . Here, DNA methylation was defined as the ratio of cutting by the methylationsensitive restriction endonuclease HpaII and its methylation-insensitive isoschizomer, MspI. The signal intensity of MspI cleavage served as a reference to normalize variable HpaII-cutting expected among experimental or clinical DNA samples. The modified assay also employed binding of the incorporated biotin-dCMP residues to streptavidin-alkaline phosphatase, reaction with an alkaline phosphatase substrate, and subsequent spectrophotometric signal detection to quantify the extent of the two separate restriction enzyme digests. Similarly, the CpGlobal assay (18) makes Two-color fluorescent cytosine extension assay for the determination of global DNA methylation
Here, we present a DNA restriction enzyme-based, fluorescent cytosine extension assay (CEA) to improve normalization and technical variation among sample-to-sample measurements. The assay includes endlabeling of parallel methylation-sensitive and methylation-insensitive DNA restriction enzyme digests along with co-purification and subsequent co-measurement of incorporated fluorescence. This non-radioactive, two-color fluorescent CEA (TCF-CEA) was shown to be a relatively rapid and accurate, with 3-fold greater precision than the one-color CEA. In addition, TCF-CEA provided an index of global DNA methylation that was sensitive to differences >5%. TCF-CEA results were highly correlated with LUminometric Methylation Assay (LUMA) results using human liver cell lines (HepG2, HepaRG, HC-04) as well as a human liver primary cell culture. Hypomethylation was observed in cells treated with the de-methylating agent 5-aza-2'-deoxycytidine. These results demonstrate that TCF-CEA provides a simple method for measuring relative degrees of global DNA methylation that could potentially be scaled up to higher-throughput formats.
Reports

METHOD SUMMARY
The two-color fluorescent cytosine extension assay (TCF-CEA) is an internally referenced global DNA methylation assay that consists of end-labeling parallel methylation-sensitive and methylation-insensitive DNA restriction enzyme digests along with co-purification and subsequent co-measurement of incorporated fluorescence. TCF-CEA was able to detect small global methylation differences between human cell lines. Here, we describe a two-color fluorescent CEA (TCF-CEA), consisting of HpaII/MspI restriction cleavage followed by overhang extension with separate incorporation of two different fluorescently labeled-dCTP nucleotides to more directly measure extension products. TCF-CEA has the original advantages of restriction enzyme-based methods-it is relatively rapid and inexpensive-while improving accuracy and precision by providing better data normalization compared with the one-color version of the assay. The applicability of TCF-CEA was demonstrated by comparing global DNA methylation levels in four human hepatic cell types, as well as in hepatocytes treated with a DNA methyltransferase inhibitor; performance was compared with the LUminometric Methylation Assay (LUMA), which uses pyrosequencing technology to detect nucleotide extension (19) .
Materials and methods
Two-color fluorescent cytosine extension assay
An aliquot of a concentrated genomic DNA stock from each biological sample was diluted to 50 ng/µl immediately prior to the start of the protocol to facilitate even distribution to microplate wells. The diluted DNA was digested in CutSmart Buffer for 30 min with a 10-fold excess of either the methylation-sensitive enzyme HpaII or the methylation-insensitive enzyme MspI, according to the manufacturer's protocol (enzymes purchased from New England Biolabs, Beverly, MA). A second portion of diluted DNA was incubated without restriction enzyme as a background control. Nucleotide extension reactions were performed separately in 25 µl reaction mixtures containing 200 ng of digested or undigested DNA (200 ng represents ~34,000 human diploid cells, given an estimated 6 pg of DNA per cell), 1.0 mM MgCl 2 , 5 pmol of Alexa-647-dCTP (for HpaII-cut DNA in one reaction) or Alexa-555-dCTP (for MspI-cut DNA in the other reaction) (Invitrogen, Carlsbad, CA), 1x PCR Buffer II and 0.5 U AmpliTaq DNA polymerase (Perkin Elmer, Foster City, CA). The 4 extension reactions were incubated at 56°C (optimal temperature) for 2 h (incorporation plateau), stopped with high-salt buffer, then combined in pairs (an undigested pair and a digested pair) and purified using the BioPrime Plus Purification Module (Invitrogen). In some experiments, eluted DNA fragments were re-purified with a G-50 micro column (GE HealthCare Life Sciences, Chicago, Il) to further reduce the unincorporated nucleotide background (up to 8-fold further reduced compared with single-step purification). Fifteen microliters of eluted solution from each sample (from ~75 µl total and containing ~80 ng of doublelabeled DNA) was placed into separate wells of a 96-well glass-bottom microwell plate (Corning Incorporated, Corning, NY).
One-color assays contained 5 pmol of Alexa-647-dCTP, and the 3 reactions (background uncut, MspI-cut, and HpaII-cut DNA) were purified separately. Five microliters of eluted solution from each sample was placed into separate wells of a 384-well glass-bottom microwell plate (Matrical Bioscience, Spokane, WA).
Plates were scanned using a Typhoon flatbed laser scanner (GE HealthCare Life Sciences) (633 nm excitation and 670 nm emission filter for Alexa 647; 532 nm excitation and 580 nm emission filter for Alexa 555) and quantified with ImageQuant software (GE HealthCare Life Sciences), carefully masking out well-wall reflections. MspI channel intensity was used as a reference to normalize the HpaII channel intensity; the normalized HpaII intensity indicated the relative DNA methylation level between experimental and standard DNA samples. A detailed protocol is available in the Supplementary Material.
LUMA assay
Genomic DNA (600 ng) was digested in a 30-µl volume, with either HpaII/EcoRI or MspI/EcoRI, in Fermentas Tango buffer (Thermo Fisher Scientific, Burlington, ON), and 15 U of each enzyme (50-100,000 U/ mL). After incubation for 4 h at 37°C, the reaction was stopped by incubation at 65°C for 20 min and then diluted with 30 µl pyrosequencing annealing buffer (Qiagen, Toronto, ON, Canada). Triplicate 20 µl DNA samples were pyrosequenced using Pyromark Gold Q96 reagents (Qiagen) on a Pyromark Q96MD system operated by version 1.0 software (Qiagen). Peak height values were exported to spreadsheet software for analysis. From a modified dispensation order of GTGTCACATGTG (20) , the last four peak heights, TGTG, were used to estimate the degree of digestion by EcoRI (ST peak heights) and MspI or HpaII (SG peak heights). Beckman Countler Canada, Mississauga, ON, Canada); settings: 488 nm excitation, PI emission at >620 nm, Alexa Fluor 488 emission at 530 ± 20 nm). Data were analyzed using WinList software (Verity Software, Topsham, ME).
Cell culture and DNA isolation
Cell lines used in this study were: HepG2 (ATCC, Manassas, VA), derived from a welldifferentiated hepatocellular carcinoma; HepRG (Invitrogen), a human hepatomaderived hepatocyte progenitor cell line; and HC-04 (Biodefense and Emerging Infections Research Resources Repository, Manassas, VA), isolated from normal tissue surrounding a human hepatoma. Human biopsy cells were obtained from Celsis (Baltimore, MD). All cell lines were cultured according to the supplier's recommendations. DNA was isolated using the DNeasy Blood and Tissue kit from Qiagen. Human non-methylated and highly methylated HCT116 DNA was obtained from Zymo Research (Irvine, CA). DNA concentration was measured using a Nanodrop spectrophotometer (Thermo Fisher Scientific, Wilmington, DE).
Results and discussion
Specificity of the one-color and two-color assay formats
The assay was designed according to the general methods published for other singlelabel (16) (17) (18) 22) CEAs and modified into a dual-label assay as depicted in Figure  1 . One-color and two-color assay performances were compared by measuring fluorescence intensity changes in serial mixtures of human unmethylated DNA and highly methylated DNA.
The linearity and precision of one-color fluorescent CEA using one-step removal of unincorporated fluorescent nucleotide was assessed. Fluorescence intensities of labeled DNA were similar for samples of either 100% methylated or unmethylated DNA digested with MspI ( Figure 2A ). The fluorescence intensities we obtained were considered to be robust assay signals since the background signals from extension reactions of undigested DNA were only 6% of the total signals (background plus specific signal) from MspI and HpaIIdigested unmethylated DNA and ~10% of the smaller total signals obtained from the 1:1 (50%) methylated mixture digested with HpaII. The signal-to-background ratio was greater than that reported for a similar single-label method for measuring DNA methylation by fluorescence polarization (22) . Although the fluorescence polarization method is sensitive and has fewer steps than TCF-CEA (the extension reactions were not purified prior to polarization measurements), assay backgrounds in the absence of DNA were about equal to the signal when measuring 100 ng of human genomic DNA. Higher signal-tobackground ratios in the TCF-CEA would allow more accurate measurement of smaller DNA samples.
As expected, methylation dilution curves demonstrated that HpaII only cut non-methylated DNA, while MspI cut both methylated and unmethylated DNA, and ratios of fluorescence intensities were dependent upon the proportion of methylated DNA. A small but significant (linear regression test, P < 0.005; t-test, P < 0.07; 0% versus 100% methylated DNA) negative dose response (≈13%) in the MspI channel indicated that the highly methylated DNA, prepared by reaction with M.SssI methylase (23) , may contain a small amount of off-site methylation at the external C in the recognition sequence CCGG, which cannot be cut by MspI. M.SssI methylase is ) and precision (coefficient of variation; CV) of the one-color (¸) and two-color () versions of the fluorescent CEA. Average CV values for the measurements in the one-color and two-color analyses were 22.6% and 6.7%, respectively (P < 0.02; t-test), calculated from the combined data from two independent dilution series measured with onecolor assays and one dilution series measured with the two-color assay (CV data shown in table inset). known to catalyze cytosine deamination to uracil at a low rate when the methyl donor S-adenosyl-methionine (SAM) is limiting, removing the restriction site for MspI digestion (24) .
Fluorescent nucleotide extension was linear, with robust signals in the tested range of 60-500 ng genomic DNA (data not shown); 25 pg of labeled DNA, spotted on a microscope slide, was detectable using a microarray scanner (data not shown), suggesting that a substantial reduction in DNA sample size is possible, which would allow assay miniaturization. In the present study, 200 ng of each DNA sample, with 40 ng carried through to the protocol end, were chosen for further validation experiments.
To reduce variability below that found in the one-color fluorescent CEA, where digests are processed separately, the TCF-CEA version of the assay combined the two restriction enzyme digests into a single solution after cytosine extension. This modification was expected to reduce fluctuations in the fluorescence signals generated during the downstream processing steps. The R 2 value for the plotted HpaII/MspI ratios along the dilution curve remained unchanged compared with the one-color assay (0.9947 compared with 0.9919), while the coefficient of variation (CV) decreased ~3.5-fold from 0.226 to 0.0668 ( Figure 2B ). Therefore, both the one-color and two-color assays accurately reported the relatively large predetermined differences in sample methylation tested in these experiments. Importantly, the 3.5-fold improvement in precision gained by including the reference digest as a second color suggested that relatively smaller differences in methylation could be detected by TCF-CEA.
Signal fluctuations in separately processed restriction enzyme digests could have occurred in the one-color assay due to (i) differences in recovery of DNA during purification of the DNA digests after labeling by nucleotide extension, (ii) differences in the amounts of the HpaII and MspI digests added individually to microplate wells, and/or (iii) well-to-well differences in reading the two fluorescence emissions. In TCF-CEA, co-processing fluorophore-labeled extension reactions and obtaining the ratio of fluorophore incorporation into the methylation sensitive/ insensitive digests in a single well helped normalize sample-to-sample variation due to measurement errors.
Sensitivity to small methylation differences TCF-CEA sensitivity was assessed by determining the minimum methylation difference that could be detected between separate samples. Small amounts of serially diluted methylated DNA or unmethylated DNA were added to DNA from HepG2 cells (50% methylated, as measured by LUMA), simulating small hyper-or hypo-methylation changes over ranges typically encountered in biological samples. TCF-CEA consistently detected as little as 7.5% hypo-or hyper-methylation relative to pure HepG2 DNA as a significant difference, when significance was corrected for multiple comparisons (Figure 3 ). Due to potential differences in reactivity and specific activity among lots of fluorophore-labeled dCTPs, similar standard curves for two-color extension labeling, generated from calibrated DNA sources, are necessary for the interpolation of unknown samples.
Estimation of DNA methylation levels among human hepatocellular sources Global DNA methylation levels were measured in DNA from three human cell lines (HepG2, HC-04, HepRG) and a primary culture of a human liver biopsy sample using TCF-CEA, and the results were compared with data from LUMA, a frequently employed global DNA methylation assay. Similar to TCF-CEA, LUMA detects differences in nucleotide extension (dGTP + dCTP) between DNA cleavages made by the HpaII and MspI isoschizomers (19) , but it uses pyrosequencing technology to detect these differences.
The results across the 4 different human liver cell cultures for both assays were highly correlated (R 2 = 0.976; P < 0.0001), and the degree of DNA methylation among the 4 cell types was significantly different ( Figure 4A ). For TCF-CEA, the CV values for the repeated measurements of the 4 DNA sources ranged 3%-9% (with a mean of 5%), a range comparable to the CV values previously determined for the dilution series of methylated and unmethylated DNA (6.7% and 3%, in Figure 2B and Figure 3 , respectively). Human liver biopsy cells showed the greatest DNA methylation, as expected, because the HepG2, HepRG, and HC-04 cell lines were all isolated from hepato-carcinomas (25, 26) or liver tumor-adjacent cells (27) , which usually exhibit DNA hypo-methylation (28) . The 4 DNA sources spanned a range differing 34% in methylation, from 73% of CCGG sites for the biopsy culture, which was comparable to the degree of DNA methylation measured in human fetal liver tissue (29) , down to 39% for HC-04 cells, as measured by LUMA. The smallest difference detected by TCF-CEA was between HepG2 and HepRG cells (5%, as measured by LUMA) and was comparable to the minimum differences detectable in the methylated DNA dilution series described above.
LUMA uses basically the same principles as a CEA, and the highly comparable relative DNA methylation results from the four different cell types confirmed that TCF-CEA provided reliable, semiquantitative measurements of genomic DNA methylation levels. It is interesting to note that similar ranges of methylation values have been measured by LUMA in peripheral blood DNA samples and have been associated with breast cancer risk (20, 30, 31) . Our results indicate that TCF-CEA could provide a simplified and accurate alternative to LUMA for detecting relative DNA methylation amounts in clinical and biobank samples, cultured cells after experimental treatments with toxins, or cell populations that have undergone oncogenic transformation or differentiation/dedifferentiation. The ability of TCF-CEA to detect altered DNA methylation levels in comparison to LUMA was confirmed in a second approach, following an experimental treatment of HepG2 cells with 0.05-50 µM of the DNA demethylating agent 5-aza-2'-deoxycytosine (5-Aza-CdR) ( Figure 4B ). As expected, TCF-CEA showed increasing HpaII/MspI ratios compared with untreated cells in response to 0.05 µM and 0.5 µM 5-Aza-CdR. However, at the 2 highest concentrations of 5-Aza-CdR (5 µM and 50 µM), the ratio substantially decreased compared with that obtained for 0.5 µM treatment, with 50 µM having a significantly lower ratio. A similar trend was also detected by LUMA. In contrast to the two restriction enzyme-based assays, antibody-based flow-cytometric detection of methylated deoxycytosine decreased continuously across the full range of 5-Aza-CdR concentrations. These data suggest interference with restriction enzyme site recognition by 5-Aza-CdR incorporation at high concentrations. Indeed, labeling of HpaII-digested DNA from cells treated with 5 µM or 50 µM 5-Aza-CdR was greatly reduced relative to the reference MspI-digested DNA, which was affected to a lesser extent, decreasing ~30% relative to DNA from cells treated with 0.5 µM 5-Aza-CdR (data not shown) Confounding effects of DNA adducts on restriction enzymes and polymerases need to be considered, such as the previously documented effects of benzo[a]pyrene adducts (32) .
Several features of TCF-CEA would permit further assay development supporting higher throughput of DNA samples, such as in biobank specimen 
Uniquely designed for when precision is paramount
The new Applied Biosystems of error through (i) reducing DNA purification steps by combining two DNA digests into a single tube, (ii) reducing sample dispensation steps by performing extensions of HpaII and MspI digests on one sub-sample of DNA, and (iii) reducing fluorescence measurement variability by obtaining both extension signals from a single multi-well plate per sample;
• No cytosine base modification requirement (e.g., bisulfite treatment); • Cost-effective labeling and detection because (i) standard laboratory equipment is used for fluorescence detection and (ii) labeling with fluorescent nucleotides is highly efficient. For example, 0.05 µmol of each commercially available Alexamodified dCTP is sufficient for 5000 assays-when using 5 pmol per extension step with 1 background extension for each uncut DNA sample plus a corresponding extension of DNA cut with a methylationsensitive or -insensitive restriction enzyme (Figures 1 and 3) . The total assay number per fluorescent nucleotide lot could be increased several-fold by assay miniaturization and reduction of the amount of DNA sample required.
• Extension reactions in multi-well plates could be coupled to product purification in a multi-well format to facilitate automated processing.
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